{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:24:58Z","timestamp":1793679898903,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02103-w","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T02:57:02Z","timestamp":1739761022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive pan-cancer analysis of HSPG2 as a marker for prognosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Fangjun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"16","key":"2103_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029\u201330.","journal-title":"Cancer"},{"issue":"5","key":"2103_CR2","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.esmoop.2021.100255","volume":"6","author":"L You","year":"2021","unstructured":"You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q. Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open. 2021;6(5):100255.","journal-title":"ESMO Open"},{"issue":"1","key":"2103_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2103_CR4","doi-asserted-by":"crossref","unstructured":"Teng Y, Xia C, Li H, Cao M, Yang F, Yan X, He S, Cao M, Zhang S, Li Q et al. Cancer statistics for young adults aged 20 to 49 years in China from 2000 to 2017: a population-based registry study. Sci China Life Sci. 2023;67(4):711\u201319.","DOI":"10.1007\/s11427-023-2445-1"},{"key":"2103_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","volume":"42","author":"RV Iozzo","year":"2015","unstructured":"Iozzo RV, Schaefer L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11\u201355.","journal-title":"Matrix Biol"},{"key":"2103_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2013.08.004","volume":"34","author":"MC Farach-Carson","year":"2014","unstructured":"Farach-Carson MC, Warren CR, Harrington DA, Carson DD. Border patrol: insights into the unique role of perlecan\/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 2014;34:64\u201379.","journal-title":"Matrix Biol"},{"key":"2103_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.matbio.2018.02.013","volume":"68\u201369","author":"MS Lord","year":"2018","unstructured":"Lord MS, Tang F, Rnjak-Kovacina J, Smith JGW, Melrose J, Whitelock JM. The multifaceted roles of perlecan in fibrosis. Matrix Biol. 2018;68\u201369:150\u201366.","journal-title":"Matrix Biol"},{"issue":"7","key":"2103_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/jcb.24788","volume":"115","author":"CR Warren","year":"2014","unstructured":"Warren CR, Grindel BJ, Francis L, Carson DD, Farach-Carson MC. Transcriptional activation by NF\u03baB increases perlecan\/HSPG2 expression in the desmoplastic prostate tumor microenvironment. J Cell Biochem. 2014;115(7):1322\u201333.","journal-title":"J Cell Biochem"},{"key":"2103_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2014.04.005","volume":"36","author":"BJ Grindel","year":"2014","unstructured":"Grindel BJ, Martinez JR, Pennington CL, Muldoon M, Stave J, Chung LW, Farach-Carson MC. Matrilysin\/matrix metalloproteinase-7(MMP7) cleavage of perlecan\/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol. 2014;36:64\u201376.","journal-title":"Matrix Biol"},{"issue":"1","key":"2103_CR10","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1038\/s41598-018-25435-3","volume":"8","author":"BJ Grindel","year":"2018","unstructured":"Grindel BJ, Martinez JR, Tellman TV, Harrington DA, Zafar H, Nakhleh L, Chung LW, Farach-Carson MC. Matrilysin\/MMP-7 Cleavage of Perlecan\/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells. Sci Rep. 2018;8(1):7262.","journal-title":"Sci Rep"},{"issue":"6","key":"2103_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41419-020-2694-7","volume":"11","author":"X Zhou","year":"2020","unstructured":"Zhou X, Liang S, Zhan Q, Yang L, Chi J, Wang L. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. Cell Death Dis. 2020;11(6):492.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2103_CR12","doi-asserted-by":"publisher","first-page":"12492","DOI":"10.1038\/s41598-019-48993-6","volume":"9","author":"S Kalscheuer","year":"2019","unstructured":"Kalscheuer S, Khanna V, Kim H, Li S, Sachdev D, DeCarlo A, Yang D, Panyam J. Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer. Sci Rep. 2019;9(1):12492.","journal-title":"Sci Rep"},{"issue":"16","key":"2103_CR13","doi-asserted-by":"publisher","first-page":"10973","DOI":"10.1074\/jbc.M112.434340","volume":"288","author":"H Hu","year":"2013","unstructured":"Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, et al. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). J Biol Chem. 2013;288(16):10973\u201385.","journal-title":"J Biol Chem"},{"key":"2103_CR14","doi-asserted-by":"crossref","unstructured":"Zhang W, Lin Z, Shi F, Wang Q, Kong Y, Ren Y, Lyu J, Sheng C, Li Y, Qin H et al. HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer. Cancers. 2022;14(14):3495.","DOI":"10.3390\/cancers14143495"},{"issue":"20","key":"2103_CR15","first-page":"6853","volume":"22","author":"XL Ma","year":"2018","unstructured":"Ma XL, Shang F, Ni W, Zhu J, Luo B, Zhang YQ. Increased HSPG2 expression independently predicts poor survival in patients with oligoastrocytoma and oligodendroglioma. Eur Rev Med Pharmacol Sci. 2018;22(20):6853\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"2103_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00418-018-1631-7","volume":"149","author":"GM Kazanskaya","year":"2018","unstructured":"Kazanskaya GM, Tsidulko AY, Volkov AM, Kiselev RS, Suhovskih AV, Kobozev VV, Gaytan AS, Aidagulova SV, Krivoshapkin AL, Grigorieva EV. Heparan sulfate accumulation and perlecan\/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma. Histochem Cell Biol. 2018;149(3):235\u201344.","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"2103_CR17","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41467-019-10968-6","volume":"10","author":"C Vennin","year":"2019","unstructured":"Vennin C, M\u00e9l\u00e9nec P, Rouet R, Nobis M, Cazet AS, Murphy KJ, Herrmann D, Reed DA, Lucas MC, Warren SC, et al. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Nat Commun. 2019;10(1):3637.","journal-title":"Nat Commun"},{"issue":"22","key":"2103_CR18","first-page":"5771","volume":"54","author":"IR Cohen","year":"1994","unstructured":"Cohen IR, Murdoch AD, Naso MF, Marchetti D, Berd D, Iozzo RV. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Can Res. 1994;54(22):5771\u20134.","journal-title":"Can Res"},{"key":"2103_CR19","doi-asserted-by":"crossref","unstructured":"Soloveva N, Novikova S, Farafonova T, Tikhonova O, Zgoda V. Proteomic Signature of Extracellular Vesicles Associated with Colorectal Cancer. Molecules. 2023;28(10):4227.","DOI":"10.3390\/molecules28104227"},{"issue":"3","key":"2103_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.0.CO;2-A","volume":"74","author":"K Nackaerts","year":"1997","unstructured":"Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G. Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer. 1997;74(3):335\u201345.","journal-title":"Int J Cancer"},{"issue":"2","key":"2103_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10719-018-9815-x","volume":"35","author":"MP Rangel","year":"2018","unstructured":"Rangel MP, de S\u00e1 VK, Prieto T, Martins JRM, Olivieri ER, Carraro D, Takagaki T, Capelozzi VL. Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer. Glycoconj J. 2018;35(2):233\u201342.","journal-title":"Glycoconj J"},{"key":"2103_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fgene.2020.00992","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y, Liu Y, He A, Guan B, He S, Zhang C, Kang Z, Gong Y, Li X, Zhou L. Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer. Front Genet. 2020;11:992.","journal-title":"Front Genet"},{"issue":"12","key":"2103_CR23","doi-asserted-by":"publisher","first-page":"e2245836","DOI":"10.1001\/jamanetworkopen.2022.45836","volume":"5","author":"ZX Liu","year":"2022","unstructured":"Liu ZX, Zhang XL, Zhao Q, Chen Y, Sheng H, He CY, Sun YT, Lai MY, Wu MQ, Zuo ZX, et al. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer. JAMA Netw Open. 2022;5(12):e2245836.","journal-title":"JAMA Netw Open"},{"issue":"21","key":"2103_CR24","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Can Res. 2017;77(21):e108\u201310.","journal-title":"Can Res"},{"key":"2103_CR25","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A et al.\u00a0Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","DOI":"10.1126\/science.1260419"},{"key":"2103_CR26","doi-asserted-by":"crossref","unstructured":"Liu X, Wu H, Liu Z. An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1). Cancers. 2022;14(11):2658.","DOI":"10.3390\/cancers14112658"},{"issue":"5","key":"2103_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"key":"2103_CR28","doi-asserted-by":"crossref","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509-w514.","DOI":"10.1093\/nar\/gkaa407"},{"issue":"7","key":"2103_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1200\/JCO.2017.76.8770","volume":"36","author":"CE Steuer","year":"2018","unstructured":"Steuer CE, Ramalingam SS. Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine? J Clin Oncol. 2018;36(7):631\u20132.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2103_CR30","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s00432-019-03053-4","volume":"145","author":"G Yang","year":"2019","unstructured":"Yang G, Zheng RY, Jin ZS. Correlations between microsatellite instability and the biological behaviour of tumours. J Cancer Res Clin Oncol. 2019;145(12):2891\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"2103_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrg1348","volume":"5","author":"H Ellegren","year":"2004","unstructured":"Ellegren H. Microsatellites: simple sequences with complex evolution. Nat Rev Genet. 2004;5(6):435\u201345.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"2103_CR32","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.21873\/anticanres.13857","volume":"39","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, Ghidini M, Cabiddu M, Pezzica E, Corti D, Turati L, Costanzo A, Varricchio A, Ghidini A, Barni S, et al. Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis. Anticancer Res. 2019;39(12):6431\u201341.","journal-title":"Anticancer Res"},{"key":"2103_CR33","doi-asserted-by":"crossref","unstructured":"Baylin SB, Jones PA. Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol. 2016;8(9):a019505.","DOI":"10.1101\/cshperspect.a019505"},{"issue":"1","key":"2103_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Ge D, Lu C. The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics Chromatin. 2019;12(1):71.","journal-title":"Epigenetics Chromatin"},{"issue":"D1","key":"2103_CR35","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900-d908.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"2103_CR36","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60-w64.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2103_CR37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/med.21765","volume":"41","author":"H Sadeghi Rad","year":"2021","unstructured":"Sadeghi Rad H, Monkman J, Warkiani ME, Ladwa R, O\u2019Byrne K, Rezaei N, Kulasinghe A. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev. 2021;41(3):1474\u201398.","journal-title":"Med Res Rev"},{"issue":"6","key":"2103_CR38","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR. Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity. Clin Cancer Res. 2023;29(6):1009\u201316.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2103_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41423-020-00613-4","volume":"18","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Marchesi F, Jaillon S, Garlanda C, Allavena P. Tumor-associated myeloid cells: diversity and therapeutic targeting. Cell Mol Immunol. 2021;18(3):566\u201378.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"2103_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, Preall J, Tuveson DA. IL1-Induced JAK\/STAT Signaling Is Antagonized by TGF\u03b2 to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancer Discov. 2019;9(2):282\u2013301.","journal-title":"Cancer Discov"},{"issue":"3","key":"2103_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"5","key":"2103_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"A Calon","year":"2012","unstructured":"Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, C\u00e9spedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, et al. Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation. Cancer Cell. 2012;22(5):571\u201384.","journal-title":"Cancer Cell"},{"key":"2103_CR43","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.pharmthera.2020.107754","volume":"221","author":"C Zhang","year":"2021","unstructured":"Zhang C, Liu J, Wang J, Hu W, Feng Z. The emerging role of leukemia inhibitory factor in cancer and therapy. Pharmacol Ther. 2021;221:107754.","journal-title":"Pharmacol Ther"},{"key":"2103_CR44","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Caballero M, Sokol L, Cuypers A, Carmeliet P. Metabolic Reprogramming in Tumor Endothelial Cells. Int J Mol Sci. 2022;23(19):11052.","DOI":"10.3390\/ijms231911052"},{"issue":"1","key":"2103_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-022-00904-5","volume":"20","author":"J Gao","year":"2022","unstructured":"Gao J, Zhang X, Jiang L, Li Y, Zheng Q. Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling. Cell Commun Signal. 2022;20(1):97.","journal-title":"Cell Commun Signal"},{"key":"2103_CR46","doi-asserted-by":"crossref","unstructured":"Pfeifer GP. Defining Driver DNA Methylation Changes in Human Cancer. Int J Mol Sci.\u00a02018;19(4).","DOI":"10.3390\/ijms19041166"},{"issue":"6","key":"2103_CR47","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","volume":"28","author":"KD Courtney","year":"2010","unstructured":"Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010;28(6):1075\u201383.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2103_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cac2.12392","volume":"43","author":"Z Fang","year":"2023","unstructured":"Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu J, Liang C, Hua J, Zhao Y, Yu X, et al. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. Cancer Commun (Lond). 2023;43(1):3\u201341.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"2103_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13046-017-0495-3","volume":"36","author":"HW Cheng","year":"2017","unstructured":"Cheng HW, Chen YF, Wong JM, Weng CW, Chen HY, Yu SL, Chen HW, Yuan A, Chen JJ. Cancer cells increase endothelial cell tube formation and survival by activating the PI3K\/Akt signalling pathway. J Exp Clin Cancer Res. 2017;36(1):27.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02103-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T14:35:16Z","timestamp":1739802916000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02103-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02103-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}